Publications by Paul Kent Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities Early Experiences with Triple Immunochemotherapy in High-Risk Fibrolamellar Carcinoma